-
IRBs often are involved with studies that involve sites in other states, which raise a host of concerns and complications.
-
For the first time, newly proposed guidance puts a number and a cost to the respirators needed to protect health care workers during an influenza pandemic: 480 respirators at a cost of about $240 to protect a single employee, or a single reusable elastomeric respirator with three filters at a cost of $40 per employee.
-
-
By ignoring red flags of dangers posed to patients subjected to tests of hemoglobin-based blood substitutes (HBBS), the U.S. Food and Drug Administration (FDA) allowed trials to continue when stopping them eight years ago would have saved lives, a blistering report released in April asserts.
-
When research calls for recruiting patients with Alzheimer's disease and other forms of dementia, it's often hard to know whether patients would want to participate had they been able to make the decision themselves.
-
In the wake of complaints from doctors who said a November 2007 opinion from the American College of Obstetricians and Gynecologists (ACOG) threatened their rights of conscience, ACOG has issued a statement insisting it "affirms the importance of conscience in shaping ethical professional conduct" and will re-examine the controversial opinion, which states that physicians who oppose sterilization and abortion are compelled to refer patients to doctors who don't object to the procedures.
-
A physician working in a clinic that sees a high percentage of minority patients who live in public housing reports a difficult time obtaining reports from other providers; his peers in more affluent parts of town who see fewer minority patients report no such delays.
-
Genetics research tells us that every person has as many as six or even more genetic mutations placing him or her at risk for some disease.
-
"At what price is cure a goal? And what price does hope carry?" Lindsay E. Rockwell, MD, a Northampton, MA oncologist, wrote in a 2007 JAMA article.
-
The Centers for Disease Control and Prevention is requesting comments on its proposed guidance on antiviral prophylaxis during an influenza pandemic.